Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NINFE study of nebivolol + hydrochlorothiazide versus irbesartan + hydrochlorothiazide in newly diagnosed hypertension
2008-002314-21Phase 4Completed
- Sponsor
- Menarini Group
- Start
- Jul 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of nebivolol, irbesartan and hydrochlorothiazide in essential hypertension (2 arms), sponsored by Menarini Group. Started Jul 2008; status: completed.
02
Drugs
nebivololirbesartanhydrochlorothiazide
03
Conditions
essential hypertension
Beyond the preview
Go deeper on 2008-002314-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-002314-21.